IV. Carcinoma Della Prostata: Interrogativi E Prospettive

Goffrini P. , Bezzi E. , Zanella E. : La linfografia retrograda e l'esame morfologico della linfa del dotto toracico. Arch. it. Chir., 87; 648 (1961).

Byar D. P. , Corle D. K. , V.A.C.U.R.G.: Vacurg randomized trial of radical prostatectomy for stages I and II prostate cancer. Urology, 17; 7 (1981).

Grayhack J. T. , Bockrath J. M. : Diagnosis of carcinoma of prostate. Urology, 17; 54 (1981).

Nachtgaele P. , Aftschrift M. , Voet D. , De Sy W. , Verdonk G. : Transabdominal real-time sonographic sector-scanning of bladder, seminal vesicles and prostate; technique and normal anatomy. Urol. Res., 10; 259 (1982).

Resnick M. I. : Ultrasound evaluation of the prostate and bladder. Seminars in Ultrasound. 1; 69 (1980).

Resnick M. I. : Non-invasive techniques in evaluating patients with carcinoma of prostate. In: Prostate Cancer Today, N.P.C.P. Urology, 17; 7 1981).

Bezzi E. , Stagni G. , Potenzoni D. , Santini R. , Valenti G. , Banchini A. : Associazioni terapeutiche nel carcinoma della prostata. 28° Conv. Società Urologi Nord Italia, Bellagio 1979. Urologia, 47; 107 (1980).

Coffey D. S. , Isaacs J. T. : Control of prostate growth. Urology, 17; 17 (1981).

Id.: Prostate tumor biology and cell kinetics. Theory. Urology, 17; 40 (1981).

Haukaas S. A. , Kalland T. : Effects of DES and Estramustine phosphate on lymphoid cell populations and mitogen responsiveness in male mice. J. Urol., 128 (1982).

Ablin R. J. , Bhatti R. A. , Guian P. D. : Effect of estrogen on tumor-associated immunity in patients with adenocarcinoma of the prostate. Cancer Res., 38; 3702 (1978).

Arnold D. J. , Marquette M. , Hallbridge E. , Rosen N. , Usher S. : Tamoxifen therapy for metastatic prostate cancer. Proc. AACRASCO, 22; 468 (1981).

Spremulli E. N. , De Simone P. , Durant J. R. : Southern cancer study group study of nolvadex tamoxifen citrate in the treatment of advanced prostatic adenocarcinoma. Clin. Res., 29; 441 A (1981).

Sogani P. C. , Whitmore W. F. Jr. : Experience with flutamide in previously untreated patients with advanced prostatic cancer. J. Urol., 122; 640 (1979).

Narayani A. S. , Loenig S. A. , Culp D. A. : Flutamide in the treatment of metastatic carcinoma of the prostate. Brit. J. Urol., 53; 152 (1981).

Calestani F. , Stagni G. , Teronci A. , Poletti F. , Potì R. , Manotti C. , Bezzi E. : Adenocarcinoma della prostata (stadio C e D) ed emocoagulazione. Comunicaz. 31° Conv. Società Urologi Nord Italia, S. Margherita Ligure 1982. Urologia, 50; 24 (1983).

Murphy G. P. , Slack N. H. , Karr J. P. : Overview of the co-operative clinical trials of the U.S.A.N.P.C.P. Intern. Symp. Manag. Prost. Cancer, Genova 1982.

Pavone Macaluso M. , Lund F. , Mulder J. H. , Smith P. H. , De Paulu M. , Sylvester R. , EORTC Urological Group: EORTC protocols in prostatic cancer: an interim report. Scand. J. Urol. & Nephrol., Suppl., 55; 163 (1980).

Ritchie A. W. S. , James K. , Chisholm G. D. : Monoclonal antibodies to human T-lymphocyte surface antigens; their potential application to urology. Urol. Res., 10; 221 (1982).

Reinherz G. L. , Schlossman S. F. : Regulation of the immune response: inducer and suppressor T-lymphocyte subsets in human beings. N. Engl. J. Med., 303; 370 (1980).

Cosimi A. B. , Burton R. C. , Kung P. C. , Coluin R. , Goldstein G. , Lifter J. , Rhodes W. , Russel P. S. : Evaluation in primate renal allograft recipients of monoclonal antibody to human T-cell subclasses. Transpl. Proc, 13; 499 (1981).

Ellis T. M. , Mahanakamur T. : Alterations in human regulatory T-lymphocyte subpopulations after renal allografting. J. Immun. 127; 199 (1981).

Puccetti P. : Gli immunopotenziatori: problemi e prospettive del loro impiego. Aggiorn. Med., 1; 63 (1982).

Oettgen H. F. : Aspetti immunologici del cancro. Minuti, 6; 17 (1980).

Brannen G. E. , Gomolka D. M. , Coffey D. S. : Specificity of cell membrane antigens in prostatic cancer. Cancer Chemoth., Rep., 59; 127 (1975).

Sikora K. , Alderson T. , Phillips J. , Watson H. : Human hybridomas from malignant gliomas. Lancet, 1; 11 (1982).

Schlom J. , Wunderlich D. , Teramoto Y. A. : Generation of human monoclonal antibodies reactive with human carcinoma cells. Proc. Nat. Acad. Sci., 77; 6841 (1980).

Yeh M. Y. , Hellstrom J. , Brown J. P. , Warner G. A. , Hansen J. A. , Hellstrom K. E. : Cell surface antigens of human melanoma identified by monoclonal antibodies. Proc. Nat. Acad. Sci., 76; 2977 (1979).

Kaszubowski P. A. , Hasby G. , Tung K. S. K. , Williams R. C. : T-lymphocyte subpopulations in peripheral blood and tissues of cancer patients. Cancer Res., 40; 4648 (1980).

De Kernion J. B. , Katsuoka Y. , Ramming K. P. : Immunology of human renal adenocarcinoma. Report UICC, 49; 10 (1980).

Kohler G. , Milstein C. : Continuous cultures of fused cells secreting antibodies of pre-fined specificity. Nature, 256; 495 (1975).